State Street’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5K | Hold |
43,390
| – | – | ﹤0.01% | 4165 |
|
|
2025
Q1 | $31.4K | Hold |
43,390
| – | – | ﹤0.01% | 4151 |
|
|
2024
Q4 | $41.4K | Hold |
43,390
| – | – | ﹤0.01% | 4136 |
|
|
2024
Q3 | $34.2K | Hold |
43,390
| – | – | ﹤0.01% | 4159 |
|
|
2024
Q2 | $41.1K | Buy |
43,390
+27,700
| +177% | +$26.2K | ﹤0.01% | 4174 |
|
|
2024
Q1 | $16.9K | Hold |
15,690
| – | – | ﹤0.01% | 4298 |
|
|
2023
Q4 | $8.63K | Hold |
15,690
| – | – | ﹤0.01% | 4406 |
|
|
2023
Q3 | $33.1K | Hold |
15,690
| – | – | ﹤0.01% | 4366 |
|
|
2023
Q2 | $41.1K | Hold |
15,690
| – | – | ﹤0.01% | 4469 |
|
|
2023
Q1 | $49.9K | Hold |
15,690
| – | – | ﹤0.01% | 4504 |
|
|
2022
Q4 | $42.2K | Hold |
15,690
| – | – | ﹤0.01% | 4595 |
|
|
2022
Q3 | $46K | Hold |
15,690
| – | – | ﹤0.01% | 4676 |
|
|
2022
Q2 | $46K | Sell |
15,690
-78,171
| -83% | -$229K | ﹤0.01% | 4738 |
|
|
2022
Q1 | $664K | Buy |
93,861
+34,651
| +59% | +$245K | ﹤0.01% | 3937 |
|
|
2021
Q4 | $947K | Buy |
+59,210
| New | +$947K | ﹤0.01% | 3826 |
|